Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Net Cash Flow: 2019-2024

Historic Net Cash Flow for Bright Minds Biosciences (DRUG) over the last 6 years, with Sep 2024 value amounting to -$764,327.

  • Bright Minds Biosciences' Net Cash Flow fell 2415.32% to -$9.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $14.7 million, marking a year-over-year change of. This contributed to the annual value of -$764,327 for FY2024, which is 78.68% up from last year.
  • Bright Minds Biosciences' Net Cash Flow amounted to -$764,327 in FY2024, which was up 78.68% from -$3.6 million recorded in FY2023.
  • In the past 5 years, Bright Minds Biosciences' Net Cash Flow registered a high of $14.8 million during FY2021, and its lowest value of -$6.6 million during FY2022.
  • In the last 3 years, Bright Minds Biosciences' Net Cash Flow had a median value of -$3.6 million in 2023 and averaged -$3.6 million.
  • As far as peak fluctuations go, Bright Minds Biosciences' Net Cash Flow spiked by 2,667.80% in 2021, and later tumbled by 144.34% in 2022.
  • Bright Minds Biosciences' Net Cash Flow (Yearly) stood at $535,616 in 2020, then spiked by 2,667.80% to $14.8 million in 2021, then slumped by 144.34% to -$6.6 million in 2022, then skyrocketed by 45.45% to -$3.6 million in 2023, then spiked by 78.68% to -$764,327 in 2024.